These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22172889)

  • 1. Recurrent membranoproliferative glomerulonephritis after second renal graft treated with plasmapheresis and rituximab.
    Pérez-Sáez MJ; Toledo K; Navarro MD; Lopez-Andreu M; Redondo MD; Ortega R; Pérez-Seoane C; Agüera ML; Rodríguez-Benot A; Aljama P
    Transplant Proc; 2011 Dec; 43(10):4005-9. PubMed ID: 22172889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment-resistant recurrent membranoproliferative glomerulonephritis in renal allograft responding to rituximab: case report.
    Farooqui M; Alsaad K; Aloudah N; Alhamdan H
    Transplant Proc; 2015 Apr; 47(3):823-6. PubMed ID: 25891740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab.
    Guiard E; Karras A; Plaisier E; Duong Van Huyen JP; Fakhouri F; Rougier JP; Noel LH; Callard P; Delahousse M; Ronco P
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1609-16. PubMed ID: 21700823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent membranoproliferative glomerulonephritis after kidney transplantation.
    Lorenz EC; Sethi S; Leung N; Dispenzieri A; Fervenza FC; Cosio FG
    Kidney Int; 2010 Apr; 77(8):721-8. PubMed ID: 20130531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
    Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
    Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A
    Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of membranoproliferative glomerulonephritis type II with plasmapheresis.
    Kurtz KA; Schlueter AJ
    J Clin Apher; 2002; 17(3):135-7. PubMed ID: 12378549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience.
    Braun MC; Stablein DM; Hamiwka LA; Bell L; Bartosh SM; Strife CF
    J Am Soc Nephrol; 2005 Jul; 16(7):2225-33. PubMed ID: 15888559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence.
    Chikamoto H; Hattori M; Kuroda N; Kajiho Y; Matsumura H; Fujii H; Ishizuka K; Hisano M; Akioka Y; Nozu K; Kaito H; Shimizu M
    Pediatr Transplant; 2012 Nov; 16(7):E286-90. PubMed ID: 22129369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful rituximab therapy for MALT lymphoma complicating cryoglobulinemic glomerulonephritis].
    Akiyama K; Itabashi M; Shiohira S; Tsuruta Y; Shimizu A; Kamiyama M; Ishihara M; Otsubo S; Takei T; Taneda S; Honda K; Nitta K
    Nihon Jinzo Gakkai Shi; 2011; 53(5):713-8. PubMed ID: 21842606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent, post-kidney transplant membranoproliferative glomerulonephritis with plasmapheresis and rituximab: A case report and literature review
.
    Yango AF; Fischbach BV; Ruiz R; Mudrovich S; Klintmalm G
    Clin Nephrol; 2019 Jan; 91(1):52-58. PubMed ID: 30431428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation.
    Marques ID; Ramalho J; David DR; Nahas WC; David-Neto E
    Int Urol Nephrol; 2014 Oct; 46(10):2053-4. PubMed ID: 25080208
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrence of membranoproliferative glomerulonephritis post transplant - Is this mere recurrence of pattern or recurrence of disease?
    Lingaraj U; Patil SR; Aralapuram K; Mallappa SS; Gurusiddaiah SC; Vankalakunti M
    Saudi J Kidney Dis Transpl; 2019; 30(3):719-722. PubMed ID: 31249240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
    Masutani K; Katafuchi R; Ikeda H; Yamamoto H; Motoyama K; Sugitani A; Kanai H; Kumagai H; Hirakata H; Tanaka M; Iida M
    Clin Transplant; 2005; 19 Suppl 14():59-64. PubMed ID: 15955171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prominent subepithelial deposits detected on 2nd renal biopsy in a boy with membranoproliferative glomerulonephritis type I: a case report].
    Motoyama O; Ohshima M; Kawamura S; Iitaka K
    Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):247-52. PubMed ID: 7602812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.
    Audard V; Kamar N; Sahali D; Cardeau-Desangles I; Homs S; Remy P; Aouizerate J; Matignon M; Rostaing L; Lang P; Grimbert P
    Transpl Int; 2012 May; 25(5):e62-6. PubMed ID: 22409658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis.
    Damodar A; Mustafa R; Bhatnagar J; Panesar M; Gundroo A; Zachariah M; Blessios G; Tornatore K; Weber-Shrikant E; Venuto R
    Clin Transplant; 2011; 25(3):375-9. PubMed ID: 20384712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.